Stay updated on Canakinumab with Docetaxel in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.

Latest updates to the Canakinumab with Docetaxel in NSCLC: Clinical Trial page
- Check3 days agoChange DetectedUpdated to Revision: v3.0.2 and removed the 'Back to Top' link; overall a minor update with no impact on core content or key data.SummaryDifference0.5%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.5%
- Check18 days agoChange DetectedThe web page has added a facility name and location details, while removing specific location terms and listed countries. This indicates a shift towards providing clearer and more relevant information about the facility's location.SummaryDifference73%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Canakinumab with Docetaxel in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.